TENAX THERAPEUTICS, INC. — Net Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/37202dcd-f72a-4b08-b7e7-a318237e6b8d/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-52.6M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-168580 |
| FY 2024 | $-17.6M | 2024-01-01 – 2024-12-31 | evidence 0001193125-26-168580 |
| FY 2023 | $-7.7M | 2023-01-01 – 2023-12-31 | evidence 0001193125-26-168580 |
| FY 2022 | $11.0M | 2022-01-01 – 2022-12-31 | evidence 0001654954-24-003827 |
| FY 2021 | $-32.5M | 2021-01-01 – 2021-12-31 | evidence 0001654954-22-004036 |
| FY 2020 | $-9.9M | 2020-01-01 – 2020-12-31 | evidence 0001654954-21-003641 |
| FY 2019 | $-8.4M | 2019-01-01 – 2019-12-31 | evidence 0001654954-20-003498 |
| FY 2018 | $-14.1M | 2018-01-01 – 2018-12-31 | evidence 0001654954-19-003861 |
| FY 2017 | $-8.8M | 2017-01-01 – 2017-12-31 | evidence 0001654954-18-003517 |
| FY 2016 | $-43.9M | 2016-01-01 – 2016-12-31 | evidence 0001654954-17-002098 |
| FY 2014 | $-14.1M | 2014-05-01 – 2015-04-30 | evidence 0001354488-15-003333 |
| FY 2013 | $-19.5M | 2013-05-01 – 2014-04-30 | evidence 0001354488-14-003782 |
| FY 2012 | $-9.4M | 2012-05-01 – 2013-04-30 | evidence 0001354488-13-003629 |
| FY 2011 | $107.6M | 1967-05-26 – 2012-04-30 | evidence 0001354488-12-003634 |
| FY 2010 | $10.4M | 2010-05-01 – 2011-04-30 | evidence 0001354488-12-003634 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TENAX THERAPEUTICS, INC. — all facts · Revenue · Operating Income